Funding · Company
Syncromune, Inc.
Fort Lauderdale, FLBiotech & Pharma
Syncromune, Inc. of Fort Lauderdale, FL has disclosed $145M across 1 Form D offering filed with the SEC on May 11, 2026.
$145M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$145M
Form D · May 11, 2026 ↗
Q2 2026
· 2 amendments, first filed Dec 17, 2024
Filing details
HeadquartersFort Lauderdale, FLIndustryBiotech & Pharma (Biotechnology)SEC CIK0001955312Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →